Search clinical trials for: Placebo 1

Total 64872 results

Montreal Heart Institute
Institut de Recherches Cliniques de Montreal; Royal Victoria Hospital, Canada; Queen Elizabeth II Health Sciences Centre and other collaborators

Completed

A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)

Hypertriglyceridemia

Canada
Zensun Sci. & Tech. Co., Ltd.
Zensun USA Inc.

Completed

Efficacy and Safety of Human Neuregulin-1 to Treat Stable Chronic Heart Failure (ZS-01-210)

Chronic Heart Failure

United States
MyMD Pharmaceuticals, Inc.

Completed

Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Frailty

Frailty | Sarcopenia | Aging

United States
Bioniz Therapeutics
Celerion

Completed

A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects

Safety and Tolerability in Healthy Subjects

United States
Akesobio Australia Pty Ltd

Completed

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

Atopic Dermatitis

New Zealand, Australia
Peking University
Centers for Disease Control and Prevention, China; Beijing Pinggu District... and other collaborators

Completed

Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 2)

SARS-CoV-2

China
Eleven Biotherapeutics

Completed

Phase 1 Study for Safety and Tolerability of EBI-005 Topically Administered to Eyes of Healthy Adult Subjects (EBI-005-1)

Dry Eye

United States
Aerpio Therapeutics

Completed

Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects in Male Volunteers

IBD

Canada
Zensun Sci. & Tech. Co., Ltd.

Terminated

Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients

Chronic Heart Failure

China
Zensun Sci. & Tech. Co., Ltd.

Terminated

Clinical Trial to Evaluate the Efficacy and Safety of Recombinant Human Neuregulin-1 for Subcutaneous Administration in Patients With Chronic Systolic Heart Failure

Chronic Heart Failure

China
Renibus Therapeutics, Inc.

Recruiting

An Evaluation of Patient Reported Outcomes and Clinical Outcomes

Post-Operative Complications in Cardiac Surgery

United States, Canada
Renibus Therapeutics, Inc.

Recruiting

Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery

Post-Operative Complications in Cardiac Surgery

United States, Canada
Zensun Sci. & Tech. Co., Ltd.

Terminated

Study of Efficacy on Cardiac Remodeling of Recombinant Human Neuregulin-1 in Stable Chronic Systolic Heart Failure Patients

Chronic Systolic Heart Failure

China
Zensun Sci. & Tech. Co., Ltd.

Terminated

Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients

Chronic Heart Failure

China
Zensun Sci. & Tech. Co., Ltd.

Terminated

Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients

Chronic Heart Failure

China
NoNO Inc.

Withdrawn

Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms (ENACT-2)

Subarachnoid Hemorrhage | Ruptured Intracranial Aneurysm

Canada, United States
NoNO Inc.
Arbor Vita Corporation

Completed

Evaluating Neuroprotection in Aneurysm Coiling Therapy (ENACT)

Stroke

United States, Canada
Guang'anmen Hospital of China Academy of Chinese...

Unknown

Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients

HIV Infections | Acquired Immune Deficiency Syndrome Virus

China
Medical University of Vienna
Austrian Science Fund (FWF)

Completed

Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy

Birch Pollen Allergy | Birch Pollen Related Apple Allergy

Austria
Vitae Pharmaceuticals Inc., an Allergan affiliate

Completed

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients

Psoriasis

United States
Shenzhen Precision Health Food Technology Co. Ltd...

Completed

The Efficacy of White Kidney Bean on Oral Glucose Tolerance Test

Diabetes | Sugar; Blood, High

China
Renibus Therapeutics, Inc.

Completed

Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery (START)

AKI

United States, Australia, Canada
Boehringer Ingelheim

Terminated

A Multiple Increasing Dose Safety and Tolerability Study After Inhalation Administration of BIIX 1 XX in Healthy Male Volunteers

Healthy
AstraZeneca

Active, not recruiting

Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants

COVID-19, SARS-CoV-2

Japan
NoNO Inc.
University of Calgary

Completed

Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis (ESCAPE-NEXT)

Stroke, Acute

United States, Canada, Singapore, Netherlands, Germany, Switzerland, Australia, Norway, Italy
MyMD Pharmaceuticals, Inc.

Completed

Single Ascending and Multiple Dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male and Female Adult Subjects

Hashimoto Disease

United States
University of Texas Southwestern Medical Center

Completed

Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea

Scleroderma, Localized | Morphea | Scleroderma, Circumscribed

United States
Orasis Pharmaceuticals Ltd.

Completed

Safety, Tolerability, and Efficacy of PresbiDrops (CSF-1), a Topical Ophthalmic Drug for Presbyopia

Presbyopia

Israel
Orasis Pharmaceuticals Ltd.

Completed

Safety, Tolerability and Efficacy of PresbiDrops (CSF-1) in Presbyopic Subjects

Presbyopia

Israel
PharmaEssentia
PharmaEssentia Japan K.K.

Completed

A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp

Actinic Keratosis

Japan
NoNO Inc.
University of British Columbia; University of Toronto; University of Calgary; Genome... and other collaborators

Completed

Field Randomization of Nerinetide (NA-1) Therapy in Early Responders (FRONTIER)

Acute Cerebral Ischemia

Canada
Pacira Pharmaceuticals, Inc

Completed

Study of FX005 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Osteoarthritis, Knee

United Kingdom, Spain, Canada, Austria
Nivalis Therapeutics, Inc.

Completed

MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects (SNO2)

Healthy

United States
Tasly Pharmaceutical Group Co., Ltd

Recruiting

A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.

Healthy Volunteers

China
Novartis Pharmaceuticals

Completed

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

Primary Biliary Cholangitis

United States, Germany, Russian Federation, Canada, United Kingdom, Poland
Beijing Ditan Hospital

Completed

A Study to Assess the Efficacy of HH-120 Nasal Spray for Prevention of SARS-CoV-2 Infection in Adult Close Contacts of Individuals Infected With SARS-CoV-2

SARS-CoV-2 Infection

China
Chiesi Farmaceutici S.p.A.

Completed

A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects (CHF6333 FIH)

Cystic Fibrosis | Non-Cystic Fibrosis Bronchiectasis

Belgium
University of the Incarnate Word
National Eye Institute (NEI)

Completed

Impact of Color Correcting Lenses on Color Vision Deficiency

Color Vision Defects | Color Blindness | Color Blindness, Red | Color Blindness, Green

United States
Zensun Sci. & Tech. Co., Ltd.

Recruiting

Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.

Chronic Heart Failure

China
Virios Therapeutics, Inc.

Completed

Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1 (FORTRESS)

Fibromyalgia

United States
Verona Pharma Inc

Completed

Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19

Coronavirus Infection | Covid-19 | SARS-CoV-2

United States
King's College London
Danone Nutricia Research

Completed

Pre-FIBRe Study: Predeterminants of Fibre Induced Bloating Response. (Pre-FIBRe)

Functional Bloating (Disorder)

United Kingdom
Assistance Publique - Hôpitaux de Paris
Iltoo Pharma

Completed

Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19 (LILIADE-COVID)

COVID 19

France
Mónica Marazuela Azpíroz
Alba Garcimartín Álvarez; Carolina Knott Torcal; Nerea Aguirre Moreno; Miguel Antonio... and other collaborators

Completed

Phase II Clinical Trial to Evaluate the Efficacy and Safety of the Treatment With BPL-1 in Adult Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Spain
Starpharma Pty Ltd

Completed

A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis

Bacterial Vaginosis
Kyowa Hakko Bio Co., Ltd.

Recruiting

Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function

Gastrointestinal Diseases | Healthy

Singapore
AstraZeneca

Recruiting

Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO). (PROSPERO)

Chronic Obstructive Pulmonary Disease (COPD)

China, Denmark, United States, Australia, Germany, Netherlands, Poland, Spain, United Kingdom, Korea, Republic of, Philippines, Italy, Argentina, Belgium, Bulgaria, Canada, Czechia, Finland, Hungary, India, Japan, Mexico, Norway, Port... and more
Valo Health, Inc.

Recruiting

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy (Spectra)

Proliferative Diabetic Retinopathy | Non-proliferative Diabetic Retinopathy

United States
PharmaEssentia
PharmaEssentia Japan K.K.

Completed

Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects

Healthy Volunteer

Japan
Janssen Pharmaceutical K.K.

Completed

A Study of JNJ-61393215 in Healthy Japanese Male Participants

Healthy

Japan

Search clinical trials for: Placebo 1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations